News

FDA approves Juul e-cigarette and cartridge sales
Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill ...
Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a ...
Juul can keep selling tobacco and menthol e-cigarettes, FDA decides
FDA regulators said Juul's studies show its e-cigarettes are less harmful for adult smokers, who can benefit from switching ...
FDA approves Juul's tobacco and menthol e-cigarettes
Juul Labs said on Thursday the U.S. Food and Drug Administration has authorized the sale of its e-cigarette device and refill ...
The Reynolds Center for Business Journalism9h
The FDA lets ‘risky drugs’ into the U.S. market, ProPublica reporter explains their investigation
The team spent 14 months investigating and found that the FDA had allowed more than 150 potentially unsafe drugs in the U.S.
Food Safety News3h
FDA enforces import laws against candy, seafood, cantaloupe and more
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...
STAT13h
FDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback
FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...
GSK's blood cancer drug fails to secure US FDA advisers' support
The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...
TAG24 on MSN6h
Food and Drug Administration may soon revise hormone replacement therapy warnings
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of ...